Globin Solutions

Pittsburgh, United States Founded: 2017 • Age: 9 yrs
Antidotal therapies for human poisonings are developed using neuroglobin technology.

About Globin Solutions

Globin Solutions is a company based in Pittsburgh (United States) founded in 2017.. Globin Solutions has raised $5 million across 2 funding rounds from investors including UPMC, HHS and TusPark. Globin Solutions offers products and services including Antidotal Therapies. Globin Solutions operates in a competitive market with competitors including GSK, eGenesis, Avidity Biosciences, Sutro Biopharma and Antheia, among others.

  • Headquarter Pittsburgh, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Globin Solutions, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.73 M (USD), Grant

    Feb 01, 2020

  • Investors
    UPMC

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Globin Solutions

Globin Solutions offers a comprehensive portfolio of products and services, including Antidotal Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops treatments for human poisonings using globin chemistry.

People of Globin Solutions
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 2
Employee Profiles
People
Jason J. Rose
CEO
People
Lindsey Bocian
Program Administrator
People
Xueli Wang
Chief Financial Officer
People
Jesus Tejero
Chief Scientific Officer

Unlock access to complete

Board Members and Advisors
people
Jeanne Cunicelli
Board Member
people
Mark T. Gladwin
Chairman

Unlock access to complete

Funding Insights of Globin Solutions

Globin Solutions has successfully raised a total of $5M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.73 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $1.7M
  • First Round

    (03 Jan 2018)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2020 Amount Grant - Globin Solutions Valuation

investors

HHS
Jan, 2018 Amount Series A - Globin Solutions Valuation Tuspark
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Globin Solutions

Globin Solutions has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include UPMC, HHS and TusPark. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
TusPark is operated as a science park and innovation ecosystem facilitator.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Multispecialty hospitals are operated as a nationwide chain.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Globin Solutions

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Globin Solutions

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Globin Solutions Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Globin Solutions

Globin Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, eGenesis, Avidity Biosciences, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Gene transplantation platform for humanizing pig cells is developed.
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Globin Solutions

Frequently Asked Questions about Globin Solutions

When was Globin Solutions founded?

Globin Solutions was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Globin Solutions located?

Globin Solutions is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

Is Globin Solutions a funded company?

Globin Solutions is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jan 03, 2018.

What does Globin Solutions do?

Globin Solutions was founded in 2017 and is based in Pittsburgh, United States. The company operates in the biotechnology sector, focusing on antidotal therapies for human poisonings. Its technology centers on neuroglobin (Ngb), a hemoglobin-like protein present in the brain. A genetically engineered variant, Ngb H64Q, has been developed to enhance carbon monoxide scavenging capabilities.

Who are the top competitors of Globin Solutions?

Globin Solutions's top competitors include Sutro Biopharma, Synthego and eGenesis.

What products or services does Globin Solutions offer?

Globin Solutions offers Antidotal Therapies.

Who are Globin Solutions's investors?

Globin Solutions has 3 investors. Key investors include UPMC, HHS, and TusPark.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available